Shanqi Guo - Concepedia

Author

Shanqi Guo

Tianjin Medical University ORCID

Also Known As

Bing Xia, S Guo, S. Guo, SHANQI GUO, Shan-Qi Guo, ShanQi Guo, Shanqi Guo, Shouliang Guo

101

Publications

915

Citations

H-Index

Concepts

All Affiliations

Tianjin Medical University First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Second Hospital of Tianjin Medical University Tianjin Medical University Cancer Institute and Hospital Chinese People's Liberation Army

About

Shanqi Guo is an author at Tianjin Medical University specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	556
2	Cell Biology	7	7	525
3	Health Sciences	3	3	113
4	Biochemistry	1	1	17
5	Gastroenterology	1	1	17

Shanqi Guo

Publications

814

Citations

H-Index

Page 1

	Year	Citations
LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling Yangyi Zhang, Shanqi Guo, Shuo Wang, Ecotoxicology and Environmental Safety Long-term Cadmium ExposureMir-128-3p/slc7a11 SignalingUrologyOncologyChronic Cd Exposure	2021	191
LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p Xingkang Jiang, Shanqi Guo, Yangyi Zhang, Cellular Signalling Cancer GenomicsLncrna Neat1Long Non-coding RnaCell BiologyProstatic Disease	2019	123
TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling Xingkang Jiang, Shanqi Guo, Mengyao Xu, Frontiers in Oncology	2022	94
c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia Bing Xia, Chen Tian, Shanqi Guo, Leukemia Research Hematological MalignancyC-myc Plays PartHealth SciencesMixed-phenotype Acute LeukemiaAcute Myeloid Leukemia	2014	82
Astragalus Polysaccharides Inhibits Tumorigenesis and Lipid Metabolism Through miR-138-5p/SIRT1/SREBP1 Pathway in Prostate Cancer Shanqi Guo, Baojie Ma, Xingkang Jiang, Frontiers in Pharmacology	2020	65
Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression Shanqi Guo, Peiying Yang, Xingkang Jiang, Oncotarget Epigenetic SilencingAdvanced Nsclc TissuesTumor MicroenvironmentCancer GrowthCancer Genomics	2016	56
Prognostic factors associated with solitary plasmacytoma Yizhuo Zhang, Shanqi Guo, Le Zhang, OncoTargets and Therapy	2013	34
Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress Xingkang Jiang, Changwen Zhang, Shiyong Qi, Oncotarget Tumor BiologyUrologyElevated ExpressionIron MetabolismMetalloprotein	2016	32
Exosomal lincROR Promotes Docetaxel Resistance in Prostate Cancer through a β-catenin/HIF1α Positive Feedback Loop Xingkang Jiang, Yong Xu, Ranlu Liu, Molecular Cancer Research	2023	28
LncRNA PCA3 promotes antimony-induced lipid metabolic disorder in prostate cancer by targeting MIR-132-3 P/SREBP1 signaling Shanqi Guo, Yangyi Zhang Toxicology Letters Tumor BiologyRadiation OncologyLncrna Pca3MedicineMir-132-3 P/srebp1	2021	24

Page 1